tiprankstipranks

Summit Therapeutics down 32% after resuming trading

Shares are down $11.78, or 32%, to $24.92 after trading resumed following an earlier halt.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue